Linked Data API

Show Search Form

Search Results

229255
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Visual Impairment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many finished consultant episodes with a primary or secondary diagnosis of (a) age-related macular degeneration, (b) glaucoma, (c) diabetic retinopathy and (d) cataracts there were in the NHS in England in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228836 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>The following table provided by the Health and Social Care Information Centre (HSCIC) shows the number of finished consultant episodes with a primary or secondary diagnosis of (a) age-related macular degeneration, (b) glaucoma, (c) diabetic retinopathy and (d) cataracts in the National Health Service in England between 2009/10 and 2013/14.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Age-related Macular Degeneration</p></td><td><p>Glaucoma</p></td><td><p>Diabetic Retinopathy</p></td><td><p>Cataracts</p></td></tr><tr><td><p>2009-10</p></td><td><p>100,455</p></td><td><p>95,400</p></td><td><p>63,143</p></td><td><p>381,071</p></td></tr><tr><td><p>2010-11</p></td><td><p>128,439</p></td><td><p>123,962</p></td><td><p>77,704</p></td><td><p>390,571</p></td></tr><tr><td><p>2011-12</p></td><td><p>138,202</p></td><td><p>133,061</p></td><td><p>78,419</p></td><td><p>389,181</p></td></tr><tr><td><p>2012-13</p></td><td><p>149,635</p></td><td><p>139,385</p></td><td><p>80,615</p></td><td><p>395,882</p></td></tr><tr><td><p>2013-14</p></td><td><p>152,583</p></td><td><p>156,115</p></td><td><p>93,058</p></td><td><p>437,038</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p><strong> </strong></p></td></tr><tr><td colspan="5"><p><em>Source:</em> Hospital Episode Statistics, HSCIC</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p>This data includes patients who were treated as inpatients or day cases (admitted patient care) but not patients who were treated as an outpatient.</p><p> </p><p> </p><p> </p><p>It should be noted that the data shown above is not a count of people, as the same person may have had an episode of care on more than one occasion within the same year.</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-26T14:47:03.837Zmore like thismore than 2015-03-26T14:47:03.837Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4026
label Biography information for Liz Kendall more like this
229256
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Visual Impairment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the rate was of (a) age-related macular degeneration, (b) glaucoma and (c) diabetic retinopathy per 100,000 population by age group in (i) 2013-14 and (ii) 2014-15 to date. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228837 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>Data is not collected showing the rate of age-related macular degeneration, glaucoma or diabetic retinopathy per 100,000 population, by age group.</p><p> </p><p> </p><p> </p><p>The following table provided by the Health and Social Care Information Centre shows the rate of Finished Admission Episodes with a primary diagnosis of (a) age-related macular degeneration, (b) glaucoma and (c) diabetic retinopathy per 100,000 of population, by age group in England for 2013-14 and provisional data for April 2014-November 2014.</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td colspan="3"><p>2013-14<br> Rate per 100,000 population</p></td><td colspan="3"><p>April 2014-November 14 (provisional)<br> Rate per 100,000 population</p></td></tr><tr><td><p>Age Group</p></td><td><p>Age related<br> Macular<br> Degeneration</p></td><td><p>Glaucoma</p></td><td><p>Diabetic Retinopathy</p></td><td><p>Age related<br> Macular<br> Degeneration</p></td><td><p>Glaucoma</p></td><td><p>Diabetic Retinopathy</p></td></tr><tr><td><p>0-4</p></td><td><p>0.1</p></td><td><p>11.0</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>7.6</p></td><td><p>0.0</p></td></tr><tr><td><p>5-9</p></td><td><p>0.1</p></td><td><p>3.7</p></td><td><p>0.0</p></td><td><p>0.2</p></td><td><p>2.7</p></td><td><p>0.0</p></td></tr><tr><td><p>10-14</p></td><td><p>0.3</p></td><td><p>3.0</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>2.2</p></td><td><p>0.0</p></td></tr><tr><td><p>15-19</p></td><td><p>0.3</p></td><td><p>2.8</p></td><td><p>0.4</p></td><td><p>0.2</p></td><td><p>1.4</p></td><td><p>0.7</p></td></tr><tr><td><p>20-24</p></td><td><p>1.0</p></td><td><p>3.3</p></td><td><p>4.8</p></td><td><p>0.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td></tr><tr><td><p>25-29</p></td><td><p>1.3</p></td><td><p>3.9</p></td><td><p>10.3</p></td><td><p>1.0</p></td><td><p>2.7</p></td><td><p>7.1</p></td></tr><tr><td><p>30-34</p></td><td><p>1.5</p></td><td><p>5.6</p></td><td><p>13.2</p></td><td><p>0.9</p></td><td><p>3.9</p></td><td><p>10.2</p></td></tr><tr><td><p>35-39</p></td><td><p>2.9</p></td><td><p>9.3</p></td><td><p>14.8</p></td><td><p>1.5</p></td><td><p>5.1</p></td><td><p>11.2</p></td></tr><tr><td><p>40-44</p></td><td><p>5.9</p></td><td><p>14.6</p></td><td><p>20.8</p></td><td><p>2.2</p></td><td><p>7.8</p></td><td><p>15.9</p></td></tr><tr><td><p>45-49</p></td><td><p>9.6</p></td><td><p>22.0</p></td><td><p>30.4</p></td><td><p>6.4</p></td><td><p>14.9</p></td><td><p>23.3</p></td></tr><tr><td><p>50-54</p></td><td><p>17.4</p></td><td><p>31.6</p></td><td><p>45.1</p></td><td><p>10.7</p></td><td><p>20.8</p></td><td><p>34.2</p></td></tr><tr><td><p>55-59</p></td><td><p>38.6</p></td><td><p>46.7</p></td><td><p>58.5</p></td><td><p>27.8</p></td><td><p>31.9</p></td><td><p>46.5</p></td></tr><tr><td><p>60-64</p></td><td><p>95.9</p></td><td><p>72.3</p></td><td><p>69.9</p></td><td><p>64.2</p></td><td><p>47.5</p></td><td><p>55.2</p></td></tr><tr><td><p>65-69</p></td><td><p>219.9</p></td><td><p>101.2</p></td><td><p>72.5</p></td><td><p>154.0</p></td><td><p>69.6</p></td><td><p>60.5</p></td></tr><tr><td><p>70-74</p></td><td><p>466.5</p></td><td><p>147.9</p></td><td><p>77.0</p></td><td><p>331.3</p></td><td><p>100.6</p></td><td><p>65.9</p></td></tr><tr><td><p>75-79</p></td><td><p>830.2</p></td><td><p>189.2</p></td><td><p>72.5</p></td><td><p>596.0</p></td><td><p>127.6</p></td><td><p>64.4</p></td></tr><tr><td><p>80-84</p></td><td><p>1,362.5</p></td><td><p>203.7</p></td><td><p>57.9</p></td><td><p>942.9</p></td><td><p>138.7</p></td><td><p>52.5</p></td></tr><tr><td><p>85-89</p></td><td><p>1,809.6</p></td><td><p>183.8</p></td><td><p>34.0</p></td><td><p>1,281.0</p></td><td><p>119.5</p></td><td><p>35.4</p></td></tr><tr><td><p>90 and over</p></td><td><p>1,623.6</p></td><td><p>109.5</p></td><td><p>11.5</p></td><td><p>1,239.8</p></td><td><p>69.3</p></td><td><p>13.5</p></td></tr></tbody></table><p> </p><p><em>Source:</em> Hospital Episode Statistics (HES), Health and Social Care Information Centre</p><p> </p><p><strong> </strong></p><p> </p><p>The data includes patients who were treated as inpatients or day cases (admitted patient care) but not patients who were treated as outpatients or in primary care. The rate of these diseases is likely to be much higher as some cases would not require a hospital admission.</p><p> </p><p> </p><p> </p><p>It should be noted that this is not a count of people as the same person may have had an episode of care on more than one occasion within the same year.</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-26T14:48:44.123Zmore like thismore than 2015-03-26T14:48:44.123Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4026
label Biography information for Liz Kendall more like this
229257
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Osteoporosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many finished hospital admission episodes with a primary or secondary diagnosis of fractures attributable to osteoporosis there were amongst (a) women under, (b) women over, (c) men under and (d) men over the age of 50 in 2013-14. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228838 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>The following table provides a count of finished admission episodes where there was a primary or secondary diagnosis of fractures attributable to osteoporosis amongst men, women and genders not specified for the age groups requested for the period 2013-14.</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td colspan="3"><p>Women</p></td><td colspan="3"><p>Men</p></td><td colspan="3"><p>Unknown gender</p></td></tr><tr><td><p>Aged under 50</p></td><td><p>Aged above 50</p></td><td><p>Unknown age</p></td><td><p>Aged under 50</p></td><td><p>Aged above 50</p></td><td><p>Unknown age</p></td><td><p>Aged under 50</p></td><td><p>Aged above 50</p></td><td><p>Unknown age</p></td></tr><tr><td><p>252</p></td><td><p>11,142</p></td><td><p>15</p></td><td><p>237</p></td><td><p>3,232</p></td><td><p>8</p></td><td><p>-</p></td><td><p>3</p></td><td><p>-</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><p> </p><p> </p><p>1. A finished consultant episode (FCE) is a continuous period of admitted patient care under one consultant within one healthcare provider. FCEs are counted against the year in which they end. Figures do not represent the number of different patients, as a person may have more than one episode of care within the same stay in hospital or in different stays in the same year.</p><p> </p><p> </p><p> </p><p>2. The number of episodes where this diagnosis was recorded in any of the 20 (14 from 2002-03 to 2006-07 and 7 prior to 2002-03) primary and secondary diagnosis fields in a Hospital Episode Statistics (HES) record. Each episode is only counted once, even if the diagnosis is recorded in more than one diagnosis field of the record.</p><p> </p><p><strong> </strong></p><p> </p><p><em>Source:</em> Hospital Episodes Statistics (HES) Health and Social Care Information Centre.</p><p> </p><p><strong> </strong></p><p> </p>
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
question first answered
less than 2015-03-26T12:53:05.377Zmore like thismore than 2015-03-26T12:53:05.377Z
answering member
1439
label Biography information for Norman Lamb more like this
tabling member
4026
label Biography information for Liz Kendall more like this
229259
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Eyesight: Testing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many free sight tests were provided on the NHS to people aged (a) under and (b) over 60 in England in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228835 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>The table below shows how many National Health Service funded sight tests were provided in England to people aged over 60 and to other eligible groups in each of the last five years.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Aged 60 and over</p></td><td><p>5,191,773</p></td><td><p>5,305,177</p></td><td><p>5,537,930</p></td><td><p>5,480,711</p></td><td><p>5,562,847</p></td></tr><tr><td><p>Other eligible groups</p></td><td><p>6,619,878</p></td><td><p>6,633,352</p></td><td><p>6,767,797</p></td><td><p>6,858,542</p></td><td><p>7,224,583</p></td></tr><tr><td><p>Total</p></td><td><p>11,811,651</p></td><td><p>11,938,529</p></td><td><p>12,305,727</p></td><td><p>12,339,253</p></td><td><p>12,787,430</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Source:</em> Health and Social Care Information Centre</p><p> </p><p> </p><p> </p><p>Free sight tests on the NHS are available to certain eligible groups including people aged 60 and over, children under 16, those aged 16-18 in full-time education, people on low incomes and defined categories of people at particular risk of developing eye disease.</p><p> </p><p> </p><p> </p><p>Some individuals may qualify for an NHS sight test on more than one criterion. However, they would only be recorded against one criterion on the NHS sight test form. Patients are more likely to be recorded according to their clinical need rather than their age. For example, a patient aged over 60, with glaucoma is likely to be recorded in the glaucoma category only. The count for those aged 60 and over is therefore an approximate figure and may slightly underestimate.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-26T11:14:53.9Zmore like thismore than 2015-03-26T11:14:53.9Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
228804
registered interest false more like this
date less than 2015-03-20more like thismore than 2015-03-20
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Chronic Obstructive Pulmonary Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the average length of stay in hospital was for people with a primary diagnosis of chronic obstructive pulmonary disease in England in each year from 2009-10 to 2014-15. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228589 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-25more like thismore than 2015-03-25
answer text <p>The attached table gives the mean and median length of stay and the number of finished discharge episodes where length of stay was recorded for patients with a primary diagnosis of chronic obstructive pulmonary disease for years 2009-10 to 2013-14. Complete and quality checked data for 2014-15 is not yet available.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-25T14:44:40.933Zmore like thismore than 2015-03-25T14:44:40.933Z
answering member
3918
label Biography information for Jane Ellison more like this
attachment
1
file name COPD length of stay and FDEs.xlsx more like this
title COPD length of stay and FDEs 2009-14 more like this
tabling member
4026
label Biography information for Liz Kendall more like this
228806
registered interest false more like this
date less than 2015-03-20more like thismore than 2015-03-20
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Chronic Obstructive Pulmonary Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much was spent on the prescription of drugs to manage chronic obstructive pulmonary disease in the NHS in each year from 2009-10 to 2014-15. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228591 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-25more like thismore than 2015-03-25
answer text <p>The information requested cannot be provided as information on why a drug is prescribed is not collected. This is a particular issue for chronic obstructive pulmonary disease (COPD) as medicines used to treat COPD are also used to treat a number of other medical conditions, for example asthma.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-25T17:26:42.35Zmore like thismore than 2015-03-25T17:26:42.35Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
228807
registered interest false more like this
date less than 2015-03-20more like thismore than 2015-03-20
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Chronic Obstructive Pulmonary Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many people were recorded on a general practice register with a diagnosis of chronic obstructive pulmonary disease in England in each year from 2009-10 to 2014-15. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228588 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-25more like thismore than 2015-03-25
answer text <p>The Health and Social Care Information Centre (HSCIC) are able to provide the number of people recorded on the disease register and the prevalence for Chronic Obstructive Pulmonary Disease (COPD), at England level from 2009-10 to 2013-14. The data for 2014/15 are not expected to be published until the end of October 2015.</p><p> </p><p> </p><p> </p><p>As Quality and Outcomes Framework (QOF) registers are constructed to underpin indicators on quality of care, they do not necessarily equate to prevalence as may be defined by epidemiologists. For example, prevalence figures based on QOF registers may differ from prevalence from other sources because of coding and definitional issues.</p><p> </p><p> </p><p> </p><p>The number of patients on clinical registers can be used to calculate disease prevalence, expressing the number of patients on each register as a percentage of the number of patients on practices’ lists. Therefore, ‘raw prevalence’ for a clinical area is defined as:</p><p> </p><p> </p><p> </p><p><em>Raw Prevalence = (number on clinical register / number on practice list) *100</em></p><p> </p><p><strong> </strong></p><p> </p><p>Table A: Prevalence of COPD at England level, 2009/10 to 2013/14</p><p> </p><p> </p><p> </p><p>COPD Register</p><p> </p><p> </p><p> </p><p>2013/14 1,004,920</p><p> </p><p>2012/13 974,999</p><p> </p><p>2011/12 938,511</p><p> </p><p>2010/11 898,989</p><p> </p><p>2009/10 861,341</p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-25T18:00:17.84Zmore like thismore than 2015-03-25T18:00:17.84Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4026
label Biography information for Liz Kendall more like this
228871
registered interest false more like this
date less than 2015-03-20more like thismore than 2015-03-20
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Chronic Obstructive Pulmonary Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much the Government has allocated to development of new drugs and treatments for chronic obstructive pulmonary disease each year from 2009-10 to 2014-15. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228612 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-25more like thismore than 2015-03-25
answer text <p>The following table shows estimated expenditure on research relating to the development of new drugs and treatments for chronic obstructive pulmonary disease (COPD) by Research Councils, Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td><td><p>2014/15</p></td></tr><tr><td><p>Biotechnology and Biological Sciences Research Council (BBSRC)</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.0</p></td><td><p>0.0</p></td></tr><tr><td><p>Medical Research Council (MRC)</p></td><td><p>3.8</p></td><td><p>2.6</p></td><td><p>2.4</p></td><td><p>2.9</p></td><td><p>2.1</p></td><td><p>n/a</p></td></tr><tr><td><p>Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.3</p></td><td><p>1.3</p></td><td><p>1.4</p></td><td><p>0.6</p></td></tr><tr><td><p>NIHR</p></td><td><p>0.9</p></td><td><p>0.8</p></td><td><p>0.9</p></td><td><p>1.9</p></td><td><p>2.6</p></td><td><p>2.5</p></td></tr><tr><td><p>Total</p></td><td><p>4.7</p></td><td><p>3.5</p></td><td><p>3.7</p></td><td><p>6.2</p></td><td><p>6.1</p></td><td><p>n/a</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><p>1. The BBSRC funds world class bioscience and biotechnology that underpins health research funded by others, but does not fund research directly relating to understanding/treating specific diseases. The underpinning health research that the BBSRC supports seeks to provide a better understanding of what makes a healthy biological system, and the key moderators of this health (both positive and negative), and also informs strategies to help maintain resilient health across the life-course and reduce the risk of emergence of diseases typically associated with age-related health decline. In the context of COPD, the BBSRC funds a small amount of directly underpinning biotechnology work on the development of new lung tissue models.</p><p> </p><p>2. The MRC supports investigator-led research in response to proposals from the academic community and does not normally allocate funds to particular topics. High quality applications for support are welcomed into any aspect of human health and are judged in open competition with other demands on funding. Awards are made according to their scientific quality and importance to human health. The MRC also provides long term funding through our own research Units, often in partnership with Universities. In addition to research directly relating to the development of new drugs and treatments for COPD the MRC also supports a broader portfolio of research on COPD and other respiratory conditions which aims to advance our understanding and inform new treatments.</p><p> </p><p>3. The Science and Technology Facilities Council (STFC) has not funded any research into the development of new drugs and treatments for COPD. STFC’s Central Laser Facility and the Diamond Light Source have provided access for research by other organisations.</p><p> </p><p>4. Total spend by the NIHR on research relating to the development of new drugs and treatments for COPD is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these topics cannot be disaggregated from total CRN expenditure.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-25T12:56:06.617Zmore like thismore than 2015-03-25T12:56:06.617Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
228580
registered interest false more like this
date less than 2015-03-19more like thismore than 2015-03-19
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Care Quality Commission more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what proportion of safeguarding concerns responded to by the Care Quality Commission were responded to within the target time frame in each year since 2010-11. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228405 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-24more like thismore than 2015-03-24
answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care providers in England and has a key responsibility in the overall assurance of safety and quality of health and adult social care services.</p><p> </p><p> </p><p> </p><p>The CQC has provided the following information:</p><p> </p><p> </p><p> </p><p>For the period January 2013 to March 2015 the CQC had target response times for safeguarding information. There were two elements of the response time: alerts and concerns.</p><p> </p><p> </p><p> </p><p>A CQC safeguarding alert is where CQC is the first agency receiving the safeguarding information and/or there is a need for CQC to take immediate action. The local authority will be informed within 24 hours.</p><p> </p><p> </p><p> </p><p>A CQC safeguarding concern is other safeguarding information, where the CQC is not the first agency to receive the information. The CQC will risk assess the information, to determine whether regulatory action is needed. The information received will be assessed against its regulatory standards within 48 hours.</p><p> </p><p> </p><p> </p><p>The attached table shows the recorded performance against these timeframes since 1 January 2013.</p><p> </p><p> </p><p> </p><p>From April 2015, CQC will be measuring performance of the time taken to complete a range of different regulatory actions in response to safeguarding information. This will provide better information that CQC is taking appropriate action in response to information of concern.</p><p> </p>
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
question first answered
less than 2015-03-24T16:56:58.967Zmore like thismore than 2015-03-24T16:56:58.967Z
answering member
1439
label Biography information for Norman Lamb more like this
attachment
1
file name 228405 Table.docx more like this
title 228405 Table more like this
tabling member
4026
label Biography information for Liz Kendall more like this
228581
registered interest false more like this
date less than 2015-03-19more like thismore than 2015-03-19
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Chronic Obstructive Pulmonary Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many finished hospital admission episodes with a primary diagnosis of chronic obstructive pulmonary disease there were in each year since 2009-10. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 228406 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-24more like thismore than 2015-03-24
answer text <p>The attached table gives a count of finished admission episodes with a primary diagnosis of chronic obstructive pulmonary disease for years 2009-10 to 2013-14.</p><p> </p><p> </p><p> </p><p>Data on delayed transfer of care is not available in the format requested.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
grouped question UIN 228407 more like this
question first answered
less than 2015-03-24T17:37:01.167Zmore like thismore than 2015-03-24T17:37:01.167Z
answering member
3918
label Biography information for Jane Ellison more like this
attachment
1
file name Copy of 9265_PQ228406.xlsx more like this
title 228406_228407 Table more like this
tabling member
4026
label Biography information for Liz Kendall more like this